CIA
IMGN

Choate Investment Advisors’s Immunogen Inc IMGN Stock Holding History

Choate Investment Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$81K – 374
2021
Q1 		$81K Hold
10,000
– – 0.01% 269
2020
Q4 		$65K Buy
+10,000
New +$58.3K ﹤0.01% 261

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Choate Investment Advisors's IMGN Position: Q2 2021 in Review

Choate Investment Advisors sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 10,000 shares — an estimated $81K sold.

Choate Investment Advisors first reported a position in IMGN in Q4 2020 and held it in 2 quarters. The position peaked at $81K in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Choate Investment Advisors reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
  • Choate Investment Advisors sold 10,000 Immunogen Inc shares in Q2 2021, an estimated $81K.
  • Choate Investment Advisors first reported a position in Immunogen Inc in Q4 2020 and held it in 2 quarters.
  • Choate Investment Advisors's Immunogen Inc position peaked at $81K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Choate Investment Advisors's 13F filing for Q2 2021, filed 30 Jul 2021.